Valproic acid concentrations in nursing mothers, mature milk, and breastfed infants in monotherapy and combination therapy
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
31035102
DOI
10.1016/j.yebeh.2019.04.002
PII: S1525-5050(19)30121-0
Knihovny.cz E-zdroje
- Klíčová slova
- Breastfeeding, Infant, Milk, Therapeutic drug monitoring, Valproic acid,
- MeSH
- antikonvulziva krev metabolismus MeSH
- dospělí MeSH
- epilepsie farmakoterapie MeSH
- kojenec MeSH
- kojení * MeSH
- kombinovaná farmakoterapie MeSH
- komplikace těhotenství farmakoterapie MeSH
- kyselina valproová krev metabolismus MeSH
- lidé MeSH
- mateřské mléko účinky léků MeSH
- matky MeSH
- mladý dospělý MeSH
- novorozenec MeSH
- retrospektivní studie MeSH
- těhotenství MeSH
- zvířata MeSH
- Check Tag
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladý dospělý MeSH
- novorozenec MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antikonvulziva MeSH
- kyselina valproová MeSH
Valproic acid (VPA) is currently one of the four most often prescribed antiepileptic drugs (AEDs) in pregnancy. However, only a small number of studies have measured suckling infant serum levels of the drug. We studied the transport of VPA from breastfeeding mothers to the mature milk and breastfed infants and the influence of comedication with enzyme-inducing AEDs. The data of 30 nursing women treated by VPA were analyzed retrospectively. Mature milk, maternal, and infant serum levels were collected between the 6th and 32nd postnatal day and measured by gas chromatography during the years 1996-2017. Valproic acid levels varied from 5.4 to 69.0 mg/L (mean: 39.0 ± 16.1 mg/L) in the maternal serum, from <1.0 to 16.7 mg/L (mean: 1.6 ± 3.9 mg/L) in the milk, and from <1.0 to 17.5 mg/L (mean: 4.2 ± 4.3 mg/L) in the infant serum. The milk/maternal serum level ratio ranged from <0.03 to 0.25 (mean: 0.03 ± 0.06) and the infant/maternal serum level ratio from <0.03 to 0.61 (mean: 0.11 ± 0.13). Sixty-seven percent of milk and 33% of infant VPA concentrations were below the limit of quantification. No correlations were observed between maternal serum and milk levels or between maternal and infant serum levels. In conclusion, none of the milk or infant serum VPA levels reached the lower limit of the reference range used for the general population with epilepsy, so the degree of VPA exposure in breastfed infants is less than during gestation. Nevertheless, if signs of potential adverse reactions manifest, infant serum concentrations should be measured.
Citace poskytuje Crossref.org